Medicure (MCUJF) Capital Expenditures (2009 - 2021)

Medicure (MCUJF) posted quarterly Capital Expenditures of -$40460.1 for Q4 2021, up 69.13% quarter-over-quarter from -$131077.5 in Q3 2021.

Medicure (MCUJF) Capital Expenditures (2009 - 2021) Analysis & Trends

Medicure's Capital Expenditures history runs 10 years deep, the most recent figure standing at -$40460.1 for Q4 2021.

In Q4 2021, Capital Expenditures changed N/A year-over-year to -$40460.1; the TTM figure through Dec 2021 stood at -$184417.4 (changed N/A YoY), while the FY2022 annual figure was -$10768.3, up 96.42% from the prior year.
Capital Expenditures for Q4 2021 stood at -$40460.1, up from -$131077.5 in the prior quarter.
The five-year high for Capital Expenditures was -$3737.0 in Q2 2019, with the low at -$834066.4 in Q3 2017.
The 4-year median for Capital Expenditures is -$64098.9 (2018), against an average of -$183134.1.
The sharpest annual moves came in 2017 and 2018: Capital Expenditures plunged 3971.44% in 2017, then soared 98.99% in 2018.
Medicure's Capital Expenditures stood at -$834066.4 in 2017, then surged by 93.64% to -$53033.4 in 2018, then surged by 75.71% to -$12879.7 in 2019, then slumped by 214.14% to -$40460.1 in 2021.
Business Quant data shows MCUJF's Capital Expenditures at -$40460.1 in Q4 2021, -$131077.5 in Q3 2021, and -$12879.7 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Haleon	44.36 Bn	43.40 Bn	-	-
2	Teva Pharmaceutical Industries	43.76 Bn	40.11 Bn	2.15 Bn	104.00 Mn
3	Zoetis	32.39 Bn	30.71 Bn	1.05 Bn	117.00 Mn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-337.60 Mn
5	United Therapeutics	22.12 Bn	19.45 Bn	683.80 Mn	108.00 Mn
6	Viatris	18.87 Bn	17.99 Bn	1.46 Bn	52.80 Mn
7	Neurocrine Biosciences	15.64 Bn	15.25 Bn	935.80 Mn	7.80 Mn
8	Elanco Animal Health	11.99 Bn	11.46 Bn	798.00 Mn	33.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Medicure	96.01 Mn	94.89 Mn	2.57 Mn	-

Download Data